Exhibit 4.2
AMENDMENT
This Amendment to Funding Agreement is entered into as of the 30th day
of December, 2004, by and between Xxxx Xxxxxxxx ("Investor") and DNAPrint
genomics, Inc. (the "Company").
W I T N E S S E T H:
WHEREAS, the parties hereto are parties to a Funding Agreement dated on
or about October 25, 2002, (the "Agreement"), pursuant to which the Investor has
advanced certain funds to the Company; and
WHEREAS, the parties desire to memorialize the modifications in this
Amendment.
NOW, THEREFORE, in consideration of the premises and the mutual
covenants contained herein, the parties agree as follows:
1. Capitalized terms used herein but not defined herein shall have
the same meaning given to those in the Agreement.
2. The term of the Agreement and the Consideration associated
therewith are hereby amended to extend such dates for repayment
of any and all funds advanced pursuant to the Agreement, whether
or not such advances are represented by independent promissory
notes, until December 31, 2005, and the Investor shall take no
action to collect any such funds unless and until such funds
shall not have been repaid by December 31, 2005.
3. Except as explicitly modified herein, the Agreement shall remain
in full force and effect.
IN WITNESS WHEREOF, the parties have executed this Agreement as of the
date first above written.
DNAPrint genomics, Inc.
By: /s/ Xxxxxxx Xxxxxxx
--------------------------
/s/ Xxxx Xxxxxxxx
------------------------------
Xxxx Xxxxxxxx
